NJ State Employees Deferred Compensation Plan’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$157K Hold
2025
Q1
$64K Hold
2024
Q4
$79K Hold
2024
Q3
$67.8K Hold
2024
Q2
$68.3K Hold
2024
Q1
$186K Hold
2023
Q4
$195K Hold
2023
Q3
$186K Hold
2023
Q2
$263K Hold
2023
Q1
$202K Hold
2022
Q4
$271K Hold
2022
Q3
$481K Buy